Finn Guo: Driving a New Era of Accessible Gene Therapy for Hemophilia in China
Finn Guo, Director of Information Research at Illness Challenge Foundation, shared on LinkedIn:
”From launching the project in March to completing the research report ‘Payment Mechanism and Global Strategies for Innovative Hemophilia Therapies’ in June — officially presented at the International Hemophilia Conference.
We started with patient surveys to truly understand the challenges, drew insights from international best practices, and finally developed practical solution frameworks.
While the scheme is still a long way from real-world implementation, I’m truly excited that the rapid progress in China’s domestic gene therapy for hemophilia — combined with current market pricing — is set to usher China into a new era of accessible gene therapy.
Hope is on the horizon.”
Stay updated with Hemostasis Today.
-
Sep 29, 2026, 19:00Caitlin Raymond: Can Artificial Blood Solve Blood Supply Shortages?
-
Sep 29, 2026, 18:51Chaza Alaji: Dyslipidemia, Thrombosis and the DIC Diagnostic Trap
-
Sep 29, 2026, 17:31Rajnikant Patel: Bridging Ayurvedic Concepts and Modern Toxin-Mediated Disease
-
Sep 29, 2026, 17:13Nicholas Lang։ A Meaningful Case of Immune Thrombocytopenia
-
Sep 29, 2026, 16:55Ayatullah Gamal Wahab: When the CBC Lies
-
Sep 29, 2026, 16:35Jonathan Douxfils: Navigating the VTE Risk Continuum in Reproductive Medicine
-
Sep 29, 2026, 16:35Chaima Rajeh: Types of Anemia and Their Laboratory Features
-
Sep 29, 2026, 16:27Scott Isaacs: How GLP-1 RAs Target Systemic Inflammation to Drive Cardio, Autoimmune, and Gut Health
-
Sep 29, 2026, 16:21Yitshak Kreiss: From Treating Patients to Defining the Standard of Knowledge